Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKura Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.65 | -$0.63 | -$0.64 |
| Q2 2025 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2025 | 2 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2025 | 2 | -$0.38 | -$0.38 | -$0.38 |
| Q1 2026 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q2 2026 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q3 2026 | 1 | -$0.83 | -$0.83 | -$0.83 |
| Q4 2026 | 1 | $0.30 | $0.30 | $0.30 |
Kura Oncology, Inc. Earnings Date And Information
Kura Oncology, Inc. last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.65 by $0.43. The company had revenue of 53.88 M for the quarter and had revenue of 53.88 M for the year. Kura Oncology, Inc. has generated $-2 earnings per share over the last year ($-2.02 diluted earnings per share) and currently has a price-to-earnings ratio of -3.86. Kura Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Kura Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 2024 | N/A | -$0.22 | N/A | $53.82 M | $53.88 M |
| 11/07/2024 | Q3 2024 | -$0.64 | -$0.63 | 0.01 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.63 | -$0.59 | 0.04 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.56 | -$0.59 | -0.03 | N/A | $0 |
| 02/27/2024 | Q4 2023 | -$0.56 | -$0.55 | 0.01 | N/A | $1.27 M |
| 11/02/2023 | Q3 2023 | -$0.56 | -$0.50 | 0.06 | N/A | $0 |
| 08/09/2023 | Q2 2023 | N/A | -$0.53 | N/A | N/A | $0 |
| 05/10/2023 | Q1 2023 | -$0.54 | -$0.45 | 0.09 | N/A | $0 |
| 02/23/2023 | Q4 2022 | -$0.58 | -$0.49 | 0.09 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.57 | -$0.53 | 0.04 | N/A | $0 |
| 08/03/2022 | Q2 2022 | -$0.52 | -$0.53 | -0.01 | N/A | $0 |
| 05/04/2022 | Q1 2022 | -$0.52 | -$0.49 | 0.03 | N/A | $0 |
| 02/24/2022 | Q4 2021 | -$0.54 | -$0.49 | 0.05 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$0.54 | -$0.50 | 0.04 | N/A | $0 |
| 08/05/2021 | Q2 2021 | -$0.49 | -$0.51 | -0.02 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.42 | -$0.46 | -0.04 | N/A | $0 |
| 02/24/2021 | Q4 2020 | -$0.45 | -$0.45 | 0 | N/A | $0 |
| 11/05/2020 | Q3 2020 | -$0.39 | -$0.42 | -0.03 | N/A | $0 |
| 08/06/2020 | Q2 2020 | -$0.42 | -$0.40 | 0.02 | N/A | $0 |
| 05/04/2020 | Q1 2020 | -$0.42 | -$0.42 | 0 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kura Oncology, Inc. Earnings: FAQ's
Kura Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based offlast year's report dates.
In the previous quarter, Kura Oncology, Inc. (:KURA) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.65 by $0.43.
The conference call for Kura Oncology, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Kura Oncology, Inc.'s latest earnings report can be read online.
Kura Oncology, Inc. (:KURA) has a recorded annual revenue of $53.88 M.
Kura Oncology, Inc. (:KURA) has a recorded net income of $-173,983,000.Kura Oncology, Inc. has generated $-2.02 earnings per share over the last four quarters.
Kura Oncology, Inc. (:KURA) has a price-to-earnings ratio of -3.86 and price/earnings-to-growth ratio is -0.28.